Tonix Pharmaceuticals(NASDAQ:TNXP) 
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering. Its immunology product candidates include vaccines to prevent infectious diseases an...
Website: http://www.tonixpharma.com
Founded: 2007
IPO Price: $4.25 (Aug 09, 2013)
Full Time Employees: 16
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2024-11-27
P
O 19.00
H 20.00
L 18.00
C 19.00
V 21,248,680
10EMA 19.00
20EMA 19.00
60EMA 19.00
120EMA 19.00
250EMA 19.00